These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Michelon L, Meira-Lima I, Cordeiro Q, Miguita K, Breen G, Collier D, Vallada H. Neurosci Lett; 2006 Aug 07; 403(3):288-93. PubMed ID: 16787706 [Abstract] [Full Text] [Related]
4. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients. Szczepankiewicz A, Skibinska M, Suwalska A, Hauser J, Rybakowski JK. Hum Psychopharmacol; 2009 Jun 07; 24(4):287-91. PubMed ID: 19330793 [Abstract] [Full Text] [Related]
9. Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders. Iwahashi K, Nishizawa D, Narita S, Numajiri M, Murayama O, Yoshihara E, Onozawa Y, Nagahori K, Fukamauchi F, Ikeda K, Ishigooka J. Clin Neuropharmacol; 2014 Jun 07; 37(4):108-10. PubMed ID: 24992082 [Abstract] [Full Text] [Related]
10. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes. Mitjans M, Arias B, Jiménez E, Goikolea JM, Sáiz PA, García-Portilla MP, Burón P, Bobes J, Vieta E, Benabarre A. J Clin Psychopharmacol; 2015 Oct 07; 35(5):600-4. PubMed ID: 26267417 [Abstract] [Full Text] [Related]
11. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients. Szczepankiewicz A, Rybakowski JK, Suwalska A, Hauser J. Neuro Endocrinol Lett; 2011 Oct 07; 32(4):545-51. PubMed ID: 21876507 [Abstract] [Full Text] [Related]
14. Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder. McCarthy MJ, Nievergelt CM, Shekhtman T, Kripke DF, Welsh DK, Kelsoe JR. Genes Brain Behav; 2011 Nov 07; 10(8):852-61. PubMed ID: 21781277 [Abstract] [Full Text] [Related]
16. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients. Rybakowski JK, Skibinska M, Suwalska A, Leszczynska-Rodziewicz A, Kaczmarek L, Hauser J. Hum Psychopharmacol; 2011 Mar 07; 26(2):168-71. PubMed ID: 21437990 [Abstract] [Full Text] [Related]
17. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism. Adli M, Hollinde DL, Stamm T, Wiethoff K, Tsahuridu M, Kirchheiner J, Heinz A, Bauer M. Biol Psychiatry; 2007 Dec 01; 62(11):1295-302. PubMed ID: 17628506 [Abstract] [Full Text] [Related]
18. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder. Benedetti F, Poletti S, Radaelli D, Locatelli C, Pirovano A, Lorenzi C, Vai B, Bollettini I, Falini A, Smeraldi E, Colombo C. Psychopharmacology (Berl); 2015 Apr 01; 232(7):1325-36. PubMed ID: 25345732 [Abstract] [Full Text] [Related]